Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia T Freund

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Human Vaccines & Immunotherapeutics|May 25, 2021
Antibodies: what makes us strongerNatalia T Freund
The Journal of Allergy and Clinical Immunology|October 22, 2021
ReplyDavid Hagin, Natalia T Freund
Cell Host & Microbe|June 10, 2021
Unleashing natural antibodies against HIV-1Noam Ben-Shalom, Natalia T Freund
Journal of Immunology (Baltimore, Md. : 1950)|October 2, 2023
Evaluation of the Ability of AlphaFold to Predict the Three-Dimensional Structures of Antibodies and EpitopesKsenia Polonsky, Tal Pupko, Natalia T Freund
Immunology and Cell Biology|August 6, 2021
Walking down the memory lane with SARS-CoV-2 B cellsNatalia T Freund, Motti Gerlic, Ben A Croker
Current Opinion in HIV and AIDS|January 16, 2026
Monoclonal antibodies for Mpox: protective targets and therapeutic potentialPablo Guardado-Calvo, Natalia T Freund, Camila H Coelho
Journal of Immunological Methods|February 11, 2015
Amplification of highly mutated human Ig lambda light chains from an HIV-1 infected patientNatalia T Freund, Johannes F Scheid, Hugo Mouquet, et al.
Protein Engineering, Design & Selection : PEDS|October 22, 2015
Reconstitution of the receptor-binding motif of the SARS coronavirusNatalia T Freund, Anna Roitburd-Berman, Jianhua Sui, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 25, 2026
Monoclonal antibodies from COVID-19 convalescent patients target cryptic epitopes for broad SARS-CoV-2 neutralizationAakanksha Harit, Michael Mor, Ron Yefet, et al.
Plos Pathogens|May 27, 2026
Modified Anti-PstS1 Bi-specific antibodies unlock potent protection against tuberculosisAkanksha, Rania Bouzeyen, Avia Watson, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Human Vaccines & Immunotherapeutics|May 25, 2021
Antibodies: what makes us strongerNatalia T Freund
The Journal of Allergy and Clinical Immunology|October 22, 2021
ReplyDavid Hagin, Natalia T Freund
Cell Host & Microbe|June 10, 2021
Unleashing natural antibodies against HIV-1Noam Ben-Shalom, Natalia T Freund
Journal of Immunology (Baltimore, Md. : 1950)|October 2, 2023
Evaluation of the Ability of AlphaFold to Predict the Three-Dimensional Structures of Antibodies and EpitopesKsenia Polonsky, Tal Pupko, Natalia T Freund
Immunology and Cell Biology|August 6, 2021
Walking down the memory lane with SARS-CoV-2 B cellsNatalia T Freund, Motti Gerlic, Ben A Croker
Current Opinion in HIV and AIDS|January 16, 2026
Monoclonal antibodies for Mpox: protective targets and therapeutic potentialPablo Guardado-Calvo, Natalia T Freund, Camila H Coelho
Journal of Immunological Methods|February 11, 2015
Amplification of highly mutated human Ig lambda light chains from an HIV-1 infected patientNatalia T Freund, Johannes F Scheid, Hugo Mouquet, et al.
Protein Engineering, Design & Selection : PEDS|October 22, 2015
Reconstitution of the receptor-binding motif of the SARS coronavirusNatalia T Freund, Anna Roitburd-Berman, Jianhua Sui, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 25, 2026
Monoclonal antibodies from COVID-19 convalescent patients target cryptic epitopes for broad SARS-CoV-2 neutralizationAakanksha Harit, Michael Mor, Ron Yefet, et al.
Plos Pathogens|May 27, 2026
Modified Anti-PstS1 Bi-specific antibodies unlock potent protection against tuberculosisAkanksha, Rania Bouzeyen, Avia Watson, et al.
Pageof 4